ConductScience.org, home

Paper9531362

Prognostic biomarker study in pathologically staged N1 non-small cell lung cancer.

Komaki R and 8 others. Int J Radiat Oncol Biol Phys, 1998. Cited by 28 papers, by iCite.

Cite this record

ConductScience Library. Prognostic biomarker study in pathologically staged N1 non-small cell lung cancer. Papers, record 9531362. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9531362

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Prognostic biomarker study in pathologically staged N1 non-small cell lung cancer.
PubMed
Journal
Int J Radiat Oncol Biol Phys
PubMed
Year
1998
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
28
iCite
Relative citation ratio, by iCite
0.88
iCite
Revised in PubMed
2019-07-08
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Komaki RR
2Milas LL
3Ro JYJ Y
4Fujii TT
5Perkins PP
6Allen PP
7Sikes CRC R
8Mountain CFC F
9Ordonez NGN G

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AdenocarcinomaMajor topic
Carcinoma, Non-Small-Cell LungMajor topic
Carcinoma, Squamous CellMajor topic
Lung NeoplasmsMajor topic
Analysis of Variance
Apoptosis
Biomarkers
DNA, Neoplasm
Female
Follow-Up Studies
Genetic Markers
Humans
Ki-67 Antigen
Male
Middle Aged
Mitotic Index
Neoplasm Staging
Prognosis
Retrospective Studies

Source PubMed

Download CSV of topics

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 28 citations.

PMIDTitleJournalYearIn PapersSource
25628027Prognostic significance of histology after resection of brain metastases and whole brain radiotherapy in non-small cell lung cancer (NSCLC).Clin Exp Metastasis2015https://conductscience.org/library/papers/25628027PubMed
15545971Ki-67 expression and patients survival in lung cancer: systematic review of the literature with meta-analysis.Br J Cancer2004https://conductscience.org/library/papers/15545971PubMed
10735508The status of Fas and Fas ligand expression can predict recurrence of hepatocellular carcinoma.Br J Cancer2000https://conductscience.org/library/papers/10735508PubMed
10574266Both cell proliferation and apoptosis significantly predict shortened disease-free survival in hepatocellular carcinoma.Br J Cancer1999https://conductscience.org/library/papers/10574266PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
TP537157PubTator's text mininghttps://conductscience.org/library/genes/7157

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/9531362

GET https://conductscience.org/api/papers/v1/9531362/authors